Personality assessment with Temperament and Character Inventory in Parkinson's disease.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
10 2022
Historique:
received: 14 06 2022
revised: 02 08 2022
accepted: 05 08 2022
pubmed: 29 8 2022
medline: 26 10 2022
entrez: 28 8 2022
Statut: ppublish

Résumé

There is a growing interest in personality evaluation in Parkinson's disease (PD), following observations of specific temperaments in PD patients. Therefore, our objective was to evaluate personality dimensions from the Temperament and Character Inventory (TCI) in a cohort of fluctuating PD patients considered for deep brain stimulation. Fluctuating PD patients from the PREDISTIM cohort were included. Description of TCI dimensions and comparison with a French normative cohort were performed. Pearson correlations between TCI dimensions and motor, behavioral and cognitive variables were investigated. Structural and internal consistency analysis of the TCI were further assessed. The 570 PD patients presented significant higher scores in Harm Avoidance, Reward Dependence, Persistence, Self-Directedness and Cooperativeness and significant lower scores in Self-Transcendence compared to the French normative cohort; only Novelty Seeking scores were not different. Harm Avoidance and Self-directedness scores were correlated with PDQ-39 total, HAMD, HAMA scores, and anxiolytic/antidepressant treatment. Novelty Seeking scores were correlated with impulsivity. Pearson correlations between TCI dimensions, principal component analysis of TCI sub-dimensions and Cronbach's alpha coefficients showed adequate psychometric proprieties. The TCI seems to be an adequate tool to evaluate personality dimensions in PD with good structural and internal consistencies. These fluctuating PD patients also have specific personality dimensions compared to normative French population. Moreover, Harm Avoidance and Self-Directedness scores are associated with anxio-depressive state or quality of life and, and Novelty Seeking scores with impulsivity.

Identifiants

pubmed: 36030666
pii: S1353-8020(22)00260-7
doi: 10.1016/j.parkreldis.2022.08.004
pii:
doi:

Substances chimiques

Anti-Anxiety Agents 0
Antidepressive Agents 0

Banques de données

ClinicalTrials.gov
['NCT02360683']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-41

Investigateurs

Caroline Moreau (C)
Pr Luc Defebvre (PL)
Dr Nicolas Carriere (DN)
Dr Guillaume Grolez (DG)
Dr Guillaume Baille (DG)
Dr Kreisler (D)
Pr Jean-Pierre Pruvo (P)
Pr Leclerc (P)
Dr Renaud Lopes (DR)
Dr Romain Viard (DR)
Dr Gregory Kuchcinski (DG)
Mr Julien Dumont (MJ)
Pr Kathy Dujardin (PK)
Mme M Delliaux (MM)
Mrs M Brion (MM)
Dr Gustavo Touzet (DG)
Pr Nicolas Reyns (PN)
Pr Arnaud Delval (PA)
Mrs Valerie Santraine (MV)
Mrs Marie Pleuvret (MM)
Mrs Nolwen Dautrevaux (MN)
Mr Victor Laugeais (MV)
Thavarak Ouk (T)
Camille Potey (C)
Celine Leclercq (C)
Elise Gers (E)
Jean-Christophe Corvol (JC)
None Marie-Vidailhet
Elodie Hainque (E)
Marie-Laure Welter (ML)
Lucette Lacomblez (L)
David Grabli (D)
Emmanuel Roze (E)
Yulia Worbe (Y)
Cécile Delorme (C)
Hana You (H)
Jonas Ihle (J)
Raquel Guimeraes-Costa (R)
Florence Cormier-Dequaire (F)
Aurélie Méneret (A)
Andréas Hartmann (A)
Louise-Laure Mariani (LL)
Stéphane Lehericy (S)
Virginie Czernecki (V)
Fanny Pineau (F)
Frédérique Bozon (F)
Camille Huiban (C)
Eve Benchetrit (E)
Carine Karachi (C)
Soledad Navarro (S)
Philippe Cornu (P)
Arlette Welaratne (A)
Carole Dongmo-Kenfack (C)
Lise Mantisi (L)
Nathalie Jarry (N)
Sophie Aix (S)
Carine Lefort (C)
Dr Tiphaine Rouaud (DT)
Pr Philippe Damier (PP)
Pr Pascal Derkinderen (PP)
Dr Anne-Gaelle Corbille (D)
Dr Elisabeth Calvier-Auffray (DE)
Mrs Laetitia Rocher (ML)
Mrs Anne-Laure Deruet (M)
Dr Raoul Sylvie (DR)
Dr Roualdes Vincent (DR)
Mrs Le Dily Séverine (M)
Dr Ana Marques (DA)
Dr Berangere Debilly (DB)
Pr Franck Durif (PF)
Dr Philippe Derost (DP)
Dr Charlotte Beal (DC)
Carine Chassain (C)
Laure Delaby (L)
Tiphaine Vidal (T)
Pr Jean Jacques Lemaire (PJ)
Isabelle Rieu (I)
Elodie Durand (E)
Pr Alexandre Eusebio (PA)
Pr Jean-Philippe Azulay (P)
Dr Tatiana Witjas (DT)
Dr Frédérique Fluchère (DF)
Dr Stephan Grimaldi (DS)
Pr Nadine Girard (PN)
Eve Benchetrit (E)
Marie Delfini (M)
Dr Romain Carron (DR)
Pr Jean Regis (PJ)
Dr Giorgio Spatola (DG)
Camille Magnaudet (C)
Dr Ansquer Solène (DA)
Dr Benatru Isabelle (DB)
Dr Colin Olivier (DC)
Pr Houeto Jl (P)
Pr Guillevin Remy (PG)
Mrs Fradet Anne (MF)
Mrs Anziza Manssouri (MA)
Mrs Blondeau Sophie (MB)
Dr Richard Philippe (DR)
Dr Cam Philippe (DC)
Dr Page Philippe (DP)
Pr Bataille Benoit (PB)
Mrs Rabois Emilie (MR)
Mrs Guillemain Annie (MG)
Dr Drapier Sophie (DD)
Dr Frédérique Leh (DF)
Dr Alexandre Bonnet (DA)
Pr Marc Vérin (PM)
Dr Jean-Christophe Ferré (D)
Mr Jean François Houvenaghel (MJ)
Pr Claire Haegelen (PC)
Mrs Francoise Kestens (MF)
Mrs Solenn Ory (MS)
Pr Pierre Burbaud (PP)
Dr Nathalie Damon-Perriere (DN)
Pr Wassilios Meissner (PW)
Pr Francois Tison (PF)
Dr Stéphanie Bannier (DS)
Dr Elsa Krim (DE)
Pr Dominique Guehl (PD)
Sandrine Molinier-Blossier (S)
Morgan Ollivier (M)
Marion Lacoste (M)
Nicolas Auzou (N)
Marie Bonnet (M)
Pr Emmanuel Cuny (PE)
Dr Julien Engelhardt (DJ)
Olivier Branchard (O)
Clotilde Huet (C)
Julie Blanchard (J)
Pr Rascol Olivier (PR)
Dr Christine Brefel Courbon (DC)
Dr Fabienne Ory Magne (DF)
Dr Marion Simonetta Moreau (DM)
Pr Christophe Arbus (PC)
Pr Fabrice Bonneville (PF)
Dr Jean Albert Lotterie (DJ)
Marion Sarrail (M)
Charlotte Scotto d'Apollonia (C)
Pr Patrick Chaynes (PP)
Pr François Caire (PF)
Estelle Harroch (E)
Pr David Maltete (PD)
Dr Romain Lefaucheur (DR)
Dr Damien Fetter (DD)
Dr Nicolas Magne (DN)
Mrs Sandrine Bioux (MS)
Mrs Maud Loubeyre (MM)
Mrs Evangéline Bliaux (ME)
Mrs Dorothée Pouliquen (MD)
Pr Stéphane Derrey (PS)
Mrs Linda Vernon (ML)
Dr Frédéric Ziegler (DF)
Mathieu Anheim (M)
Ouhaid Lagha-Boukbiza (O)
Christine Tranchant (C)
Odile Gebus (O)
Solveig Montaut (S)
S Kremer (S)
Nadine Longato (N)
Clélie Phillips (C)
Jimmy Voirin (J)
Marie des Neiges Santin (MDN)
Dominique Chaussemy (D)
Dr Amaury Mengin (DA)
Dr Caroline Giordana (DC)
Dr Claire Marsé (DC)
Lydiane Mondot (L)
Bruno Giordana (B)
Robin Kardous (R)
Bernadette Bailet (B)
Héloise Joly (H)
Denys Fontaine (D)
Dr Aurélie Leplus (DA)
Amélie Faustini (A)
Vanessa Ferrier (V)
Pr Pierre Krystkowiak (PP)
Dr Mélissa Tir (DM)
Pr Jean-Marc Constans (P)
Sandrine Wannepain (S)
Audrey Seling (A)
Dr Michel Lefranc (DM)
Stéphanie Blin (S)
Béatrice Schuler (B)
Pr Stephane Thobois (PS)
Dr Teodor Danaila (DT)
Dr Chloe Laurencin (DC)
Pr Yves Berthezene (PY)
Dr Roxana Ameli (DR)
Helene Klinger (H)
Dr Gustavo Polo (DG)
Patrick Mertens (P)
A Nunes (A)
Elise Metereau (E)
Dr Lucie Hopes (DL)
Dr Solène Frismand (DS)
Dr Emmanuelle Schmitt (DE)
Mrs Mylène Meyer (MM)
Mrs Céline Dillier (MC)
Pr Sophie Colnat (PS)
Mrs Anne Chatelain (MA)
Dr Jean- Philippe Brandel (DJ)
Dr Cécile Hubsch (DC)
Dr Patte Karsenti (DP)
Dr Marie Lebouteux (DM)
Dr Marc Ziegler (DM)
Dr Christine Delmaire (DC)
Dr Julien Savatowky (DJ)
Mrs Juliette Vrillac (MJ)
Mrs Claire Nakache (MC)
Dr Vincent D'Hardemare (DV)
Mr Lhaouas Belamri (ML)
Dr Valérie Mesnage (DV)
Dr Cécilia Bonnet (DC)
Dr Jarbas Correa Lino (DJ)
Dr Camille Decrocq (DC)
Dr Anne Boulin (DA)
Mrs Inès Barre (MI)
Mrs Jordane Manouvrier (MJ)
Dr Bérénice Gardel (DB)
Pr Béchir Jarraya (PB)
Mrs Catherine Ziz (MC)
Mrs Lydie Prette (ML)
Mr Hassen Douzane (MH)
David Gay (D)
Robin Bonicel (R)
Fouzia El Mountassir (F)
Clara Fischer (C)
Jean-François Mangin (JF)
Marie Chupin (M)
Yann Cointepas (Y)
Bertrand Accart (B)
Patrick Gelé (P)
Florine Fievet (F)
Matthieu Chabel (M)
Virginie Derenaucourt (V)
Loïc Facon (L)
Yanick Tchantchou Njosse (YT)
Dominique Deplanque (D)
Alain Duhamel (A)
Lynda Djemmane (L)
Florence Duflot (F)

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Mathilde Boussac (M)

Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France. Electronic address: mathilde.boussac@inserm.fr.

Christophe Arbus (C)

Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.

Olivier Colin (O)

Service de neurologie, Centre Hospitalier de Brive-la-Gaillarde, France; Centre Expert Parkinson, CHU de Limoges, France.

Chloé Laurencin (C)

Service de neurologie C - Hôpital Neurologique - 59 boulevard Pinel 69003 Lyon - Hospices Civils de Lyon, France.

Alexandre Eusebio (A)

Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS 7289, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France.

Elodie Hainque (E)

Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; et Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau, F-75013, Paris, France.

Jean Christophe Corvol (JC)

Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; et Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau, F-75013, Paris, France.

Nathalie Versace (N)

Department of Neurology, Hôpital Fondation Rothschild, Paris, France.

Olivier Rascol (O)

Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.

Vanessa Rousseau (V)

Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.

Estelle Harroch (E)

Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.

Fabienne Ory-Magne (F)

Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.

Margherita Fabbri (M)

Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.

Caroline Moreau (C)

Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France.

Anne-Sophie Rolland (AS)

Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France.

Béchir Jarraya (B)

Service de Neurologie, Unité des Mouvements Anormaux, Foch Hospital, Suresnes, France; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, Saclay, France.

David Maltête (D)

Department of Neurology, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France.

Sophie Drapier (S)

Service de neurologie, CHU Rennes, CIC INSERM, 1414, Rennes, France.

Ana-Raquel Marques (AR)

Université Clermont Auvergne, CNRS, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand University Hospital, Neurology department, France.

Nicolas Auzou (N)

Institut des Maladies neurodégénératives, Pôle des neurosciences cliniques, CHU Bordeaux, France; Service de neurophysiologie clinique de l'enfant et de l'adulte, Pôle des neurosciences cliniques, CHU Bordeaux, France.

Thomas Wirth (T)

Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Institut de Génétique et de Biologie Moléculaire et Cellulaire, INSERM-U964/CNRSUMR7104/Université de Strasbourg, Illkirch-Graffenstaden, France; Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg, Strasbourg, France.

Mylène Meyer (M)

Neurology Department of the University Hospital of Nancy, CHRU de Nancy, Nancy, France.

Bruno Giordana (B)

CHU Nice, Department of Psychiatry and Psychotherapy, Nice, France.

Mélissa Tir (M)

Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's disease, Amiens University Hospital, EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP) Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK/FCRIN Network, Amiens, France.

Tiphaine Rouaud (T)

Department of Neurology, Expert Centre for Parkinson's Disease, University Hospital of Nantes, Nantes, France.

David Devos (D)

Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, Lille, NS-PARK/FCRIN Network, France.

Christine Brefel-Courbon (C)

Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, France; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Clinical Investigation Center CIC1436, University Hospital of Toulouse, NeuroToul COEN (Center of Excellence in Neurodegeneration), Toulouse, NS-PARK/FCRIN Network, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH